Financial News
Headline News about Spectrum Pharma Inc
Via Benzinga
After FDA Rejection, Spectrum Shelves Development On Poziotinib
November 25, 2022
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 25, 2022
Via Benzinga
Expert Ratings for Spectrum Pharmaceuticals
November 16, 2022
Via Benzinga
Despite Regulatory Setback, Spectrum Still "Unique Investment Opportunity," Says Analyst
September 23, 2022
Via Benzinga
After Regulatory Setback, Spectrum Pharma Secures Up To $65M In Debt Funding
September 23, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
November 16, 2022
Via Benzinga
FDA's Adcomm Gives Thumbs Down To Spectrum Pharmaceuticals' Lung Cancer Candidate
September 23, 2022
Via Benzinga
Via Benzinga
With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum Pharma
September 21, 2022
Via Benzinga
Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday
September 21, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.